|
Cambronero F, Vilchez JA, García-Honrubia A, Ruiz-Espejo F, Moreno V, Hernández-Romero D, Bonacasa B, González-Conejero R, de la Morena G, Martínez P, Climent V, Valdés M, Marín F. Plasma levels of von Willebrand factor are increased in patients with hypertrophic cardiomyopathy. Thromb Res. 2010 Jul;126(1):e46-50. doi: 10.1016/j.thromres.2010.01.010. Epub 2010 Feb 13. PubMed PMID: 20156645.
AÑO: 2010; IF: 10.407
|
20156645
|
Moreno V, Hernández-Romero D, Vilchez JA, García-Honrubia A, Cambronero F, Casas T, González J, Martínez P, Climent V, de la Morena G, Valdés M, Marín F. Serum levels of high-sensitivity troponin T: a novel marker for cardiac remodeling in hypertrophic cardiomyopathy. J Card Fail. 2010 Dec;16(12):950-6. doi: 10.1016/j.cardfail.2010.07.245. PubMed PMID: 21111984.
AÑO: 2010; IF: 3.362
|
|
Vílchez JA, Hernández-Romero D, Ruiz-Espejo F, Garcia-Honrubia A, Valdés M, Martínez-Hernández P, Marín F. Collagen peptides, interstitial remodelling and sudden cardiac death in hypertrophic cardiomyopathy. Clin Chem Lab Med. 2011 Sep;49(9):1569-71. doi: 10.1515/CCLM.2011.642. Epub 2011 Jun 13. PubMed PMID: 21663563.
AÑO: 2011; IF: 2.15
|
|
Hernández-Romero D, Jover E, Marín F, Vilchez JA, Manzano-Fernandez S, Romera M, Vicente V, Valdés M, Lip GY, Roldán V. The prognostic role of the adiponectin levels in atrial fibrillation. Eur J Clin Invest. 2013 Feb;43(2):168-73. doi: 10.1111/eci.12028. Erratum in: Eur J Clin Invest. 2013 Apr;43(4):428. PubMed PMID: 23278336.
AÑO: 2013; IF: 2.834
|
|
Hernández-Romero D, Marín F, Roldán V, Peñafiel P, Vilchez JA, Orenes-Piñero E, Giner JA, Valdés M, García-Alberola A. Comparative determination and monitoring of biomarkers of necrosis and myocardial remodeling between radiofrequency ablation and cryoablation. Pacing Clin Electrophysiol. 2013 Jan;36(1):31-6. doi: 10.1111/pace.12017. PubMed PMID: 23078110.
AÑO: 2013; IF: 1.25
|